Drug Markets/Prochlorperazine Maleate

Prochlorperazine Maleate

27 NDCs across 13 manufacturers|27 Generic,0 Brand

Prochlorperazine Maleate is used to treat anxiety disorders, dementia, nausea, psychotic disorders, schizophrenia and vomiting, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. FDA's Orange Book lists 20 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $11 million on Prochlorperazine Maleate across 756,000 claims for 424,000 beneficiaries.

Prochlorperazine Maleate is available as 27 NDCs from 13 manufacturers (27 generic, 0 brand), with NADAC prices from $0.12 to $0.17 per EAa 43% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

27

27G / 0B

Manufacturers

13

competing in market

Price Spread

$0.12 – $0.17

per EA

7d Activity

270 flat

avg +2.9% WoW · of 27 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

27 NDCs total, 27 shown

Drug Price 7d Change
PROCHLORPERAZINE 10 MG TAB
$0.1688
per EA
+1.58%
PROCHLORPERAZINE 10 MG TAB
$0.1688
per EA
+1.58%
PROCHLORPERAZINE 10 MG TAB
$0.1688
per EA
+1.58%
PROCHLORPERAZINE 10 MG TAB
$0.1688
per EA
+1.58%
PROCHLORPERAZINE 10 MG TAB
$0.1688
per EA
+1.58%
PROCHLORPERAZINE 10 MG TAB
$0.1688
per EA
+1.58%
PROCHLORPERAZINE 10 MG TAB
$0.1688
per EA
+1.58%
PROCHLORPERAZINE 10 MG TAB
$0.1688
per EA
+1.58%
PROCHLORPERAZINE 10 MG TAB
$0.1688
per EA
+1.58%
PROCHLORPERAZINE 10 MG TAB
$0.1688
per EA
+1.58%
PROCHLORPERAZINE 10 MG TAB
$0.1688
per EA
+1.58%
PROCHLORPERAZINE 10 MG TAB
$0.1688
per EA
+1.58%
PROCHLORPERAZINE 10 MG TAB
$0.1688
per EA
+1.58%
PROCHLORPERAZINE 10 MG TAB
$0.1688
per EA
+1.58%
PROCHLORPERAZINE 5 MG TABLET
$0.1179
per EA
+4.35%
PROCHLORPERAZINE 5 MG TABLET
$0.1179
per EA
+4.35%
PROCHLORPERAZINE 5 MG TABLET
$0.1179
per EA
+4.35%
PROCHLORPERAZINE 5 MG TABLET
$0.1179
per EA
+4.35%
PROCHLORPERAZINE 5 MG TABLET
$0.1179
per EA
+4.35%
PROCHLORPERAZINE 5 MG TABLET
$0.1179
per EA
+4.35%
PROCHLORPERAZINE 5 MG TABLET
$0.1179
per EA
+4.35%
PROCHLORPERAZINE 5 MG TABLET
$0.1179
per EA
+4.35%
PROCHLORPERAZINE 5 MG TABLET
$0.1179
per EA
+4.35%
PROCHLORPERAZINE 5 MG TABLET
$0.1179
per EA
+4.35%
PROCHLORPERAZINE 5 MG TABLET
$0.1179
per EA
+4.35%
PROCHLORPERAZINE 5 MG TABLET
$0.1179
per EA
+4.35%
PROCHLORPERAZINE 5 MG TABLET
$0.1179
per EA
+4.35%

Frequently Asked Questions

What is Prochlorperazine Maleate used to treat?

Prochlorperazine Maleate is used to treat anxiety disorders, dementia, nausea, psychotic disorders, schizophrenia and vomiting, per the National Library of Medicine's MED-RT classification.

When did Prochlorperazine Maleate become available as a generic?

FDA approved the first generic Prochlorperazine Maleate (ANDA) on Jan 1, 1982. The Orange Book currently lists 20 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Prochlorperazine Maleate?

In 2024, Medicare Part D spent $11 million on Prochlorperazine Maleate across 756,000 claims for 424,000 beneficiaries.

How many Prochlorperazine Maleate products are on the market?

The Prochlorperazine Maleate drug market contains 27 NDCs from 13 manufacturers — 27 generic and 0 brand products.

What is the price range for Prochlorperazine Maleate?

NADAC reference prices for Prochlorperazine Maleate range from $0.1179 to $0.1688 per EA — a 43% difference between cheapest and most expensive.

Which manufacturers make Prochlorperazine Maleate?

13 manufacturers list Prochlorperazine Maleate in NADAC. Ranked by number of NDCs, the largest are Bionpharma Inc. (4), Major Pharmaceuticals (2), Ajanta Pharma USA Inc. (2), AvPAK (2), Jubilant Cadista Pharmaceuticals Inc. (2).

How has the price of Prochlorperazine Maleate changed recently?

Over the past 7 days, 27 Prochlorperazine Maleate NDCs rose and 0 fell, with a market-wide average change of +2.9%.